Cargando…

SARS-CoV-2 mutations in Brazil: from genomics to putative clinical conditions

Due to the high rate of transmissibility, Brazil became the new COVID-19 outbreak epicenter and, since then, is being monitored to understand how SARS-CoV-2 mutates and spreads. We combined genomic and structural analysis to evaluate genomes isolated from different regions of Brazil and show that th...

Descripción completa

Detalles Bibliográficos
Autores principales: Timmers, Luis Fernando Saraiva Macedo, Peixoto, Julia Vasconcellos, Ducati, Rodrigo Gay, Bachega, José Fernando Ruggiero, de Mattos Pereira, Leandro, Caceres, Rafael Andrade, Majolo, Fernanda, da Silva, Guilherme Liberato, Anton, Débora Bublitz, Dellagostin, Odir Antônio, Henriques, João Antônio Pegas, Xavier, Léder Leal, Goettert, Márcia Inês, Laufer, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184806/
https://www.ncbi.nlm.nih.gov/pubmed/34099808
http://dx.doi.org/10.1038/s41598-021-91585-6
_version_ 1783704654595489792
author Timmers, Luis Fernando Saraiva Macedo
Peixoto, Julia Vasconcellos
Ducati, Rodrigo Gay
Bachega, José Fernando Ruggiero
de Mattos Pereira, Leandro
Caceres, Rafael Andrade
Majolo, Fernanda
da Silva, Guilherme Liberato
Anton, Débora Bublitz
Dellagostin, Odir Antônio
Henriques, João Antônio Pegas
Xavier, Léder Leal
Goettert, Márcia Inês
Laufer, Stefan
author_facet Timmers, Luis Fernando Saraiva Macedo
Peixoto, Julia Vasconcellos
Ducati, Rodrigo Gay
Bachega, José Fernando Ruggiero
de Mattos Pereira, Leandro
Caceres, Rafael Andrade
Majolo, Fernanda
da Silva, Guilherme Liberato
Anton, Débora Bublitz
Dellagostin, Odir Antônio
Henriques, João Antônio Pegas
Xavier, Léder Leal
Goettert, Márcia Inês
Laufer, Stefan
author_sort Timmers, Luis Fernando Saraiva Macedo
collection PubMed
description Due to the high rate of transmissibility, Brazil became the new COVID-19 outbreak epicenter and, since then, is being monitored to understand how SARS-CoV-2 mutates and spreads. We combined genomic and structural analysis to evaluate genomes isolated from different regions of Brazil and show that the most prevalent mutations were located in the S, N, ORF3a and ORF6 genes, which are involved in different stages of viral life cycle and its interaction with the host cells. Structural analysis brought to light the positions of these mutations on protein structures, contributing towards studies of selective structure-based drug discovery and vaccine development.
format Online
Article
Text
id pubmed-8184806
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-81848062021-06-08 SARS-CoV-2 mutations in Brazil: from genomics to putative clinical conditions Timmers, Luis Fernando Saraiva Macedo Peixoto, Julia Vasconcellos Ducati, Rodrigo Gay Bachega, José Fernando Ruggiero de Mattos Pereira, Leandro Caceres, Rafael Andrade Majolo, Fernanda da Silva, Guilherme Liberato Anton, Débora Bublitz Dellagostin, Odir Antônio Henriques, João Antônio Pegas Xavier, Léder Leal Goettert, Márcia Inês Laufer, Stefan Sci Rep Article Due to the high rate of transmissibility, Brazil became the new COVID-19 outbreak epicenter and, since then, is being monitored to understand how SARS-CoV-2 mutates and spreads. We combined genomic and structural analysis to evaluate genomes isolated from different regions of Brazil and show that the most prevalent mutations were located in the S, N, ORF3a and ORF6 genes, which are involved in different stages of viral life cycle and its interaction with the host cells. Structural analysis brought to light the positions of these mutations on protein structures, contributing towards studies of selective structure-based drug discovery and vaccine development. Nature Publishing Group UK 2021-06-07 /pmc/articles/PMC8184806/ /pubmed/34099808 http://dx.doi.org/10.1038/s41598-021-91585-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Timmers, Luis Fernando Saraiva Macedo
Peixoto, Julia Vasconcellos
Ducati, Rodrigo Gay
Bachega, José Fernando Ruggiero
de Mattos Pereira, Leandro
Caceres, Rafael Andrade
Majolo, Fernanda
da Silva, Guilherme Liberato
Anton, Débora Bublitz
Dellagostin, Odir Antônio
Henriques, João Antônio Pegas
Xavier, Léder Leal
Goettert, Márcia Inês
Laufer, Stefan
SARS-CoV-2 mutations in Brazil: from genomics to putative clinical conditions
title SARS-CoV-2 mutations in Brazil: from genomics to putative clinical conditions
title_full SARS-CoV-2 mutations in Brazil: from genomics to putative clinical conditions
title_fullStr SARS-CoV-2 mutations in Brazil: from genomics to putative clinical conditions
title_full_unstemmed SARS-CoV-2 mutations in Brazil: from genomics to putative clinical conditions
title_short SARS-CoV-2 mutations in Brazil: from genomics to putative clinical conditions
title_sort sars-cov-2 mutations in brazil: from genomics to putative clinical conditions
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184806/
https://www.ncbi.nlm.nih.gov/pubmed/34099808
http://dx.doi.org/10.1038/s41598-021-91585-6
work_keys_str_mv AT timmersluisfernandosaraivamacedo sarscov2mutationsinbrazilfromgenomicstoputativeclinicalconditions
AT peixotojuliavasconcellos sarscov2mutationsinbrazilfromgenomicstoputativeclinicalconditions
AT ducatirodrigogay sarscov2mutationsinbrazilfromgenomicstoputativeclinicalconditions
AT bachegajosefernandoruggiero sarscov2mutationsinbrazilfromgenomicstoputativeclinicalconditions
AT demattospereiraleandro sarscov2mutationsinbrazilfromgenomicstoputativeclinicalconditions
AT caceresrafaelandrade sarscov2mutationsinbrazilfromgenomicstoputativeclinicalconditions
AT majolofernanda sarscov2mutationsinbrazilfromgenomicstoputativeclinicalconditions
AT dasilvaguilhermeliberato sarscov2mutationsinbrazilfromgenomicstoputativeclinicalconditions
AT antondeborabublitz sarscov2mutationsinbrazilfromgenomicstoputativeclinicalconditions
AT dellagostinodirantonio sarscov2mutationsinbrazilfromgenomicstoputativeclinicalconditions
AT henriquesjoaoantoniopegas sarscov2mutationsinbrazilfromgenomicstoputativeclinicalconditions
AT xavierlederleal sarscov2mutationsinbrazilfromgenomicstoputativeclinicalconditions
AT goettertmarciaines sarscov2mutationsinbrazilfromgenomicstoputativeclinicalconditions
AT lauferstefan sarscov2mutationsinbrazilfromgenomicstoputativeclinicalconditions